- Home
- HLX vs MDXG Comparison
HLX vs MDXG Comparison
Compare HLX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLX
- MDXG
- Stock Information
- Founded
- HLX 1979
- MDXG 2006
- Country
- HLX United States
- MDXG United States
- Employees
- HLX N/A
- MDXG N/A
- Industry
- HLX Oilfield Services/Equipment
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- HLX Energy
- MDXG Health Care
- Exchange
- HLX Nasdaq
- MDXG Nasdaq
- Market Cap
- HLX 959.2M
- MDXG 1.1B
- IPO Year
- HLX 1997
- MDXG N/A
- Fundamental
- Price
- HLX $6.35
- MDXG $7.14
- Analyst Decision
- HLX Buy
- MDXG Buy
- Analyst Count
- HLX 3
- MDXG 1
- Target Price
- HLX $12.00
- MDXG $12.00
- AVG Volume (30 Days)
- HLX 1.2M
- MDXG 466.3K
- Earning Date
- HLX 10-22-2025
- MDXG 10-29-2025
- Dividend Yield
- HLX N/A
- MDXG N/A
- EPS Growth
- HLX N/A
- MDXG N/A
- EPS
- HLX 0.33
- MDXG 0.21
- Revenue
- HLX $1,277,904,000.00
- MDXG $363,774,000.00
- Revenue This Year
- HLX N/A
- MDXG $12.68
- Revenue Next Year
- HLX $7.34
- MDXG $8.18
- P/E Ratio
- HLX $19.40
- MDXG $33.98
- Revenue Growth
- HLX N/A
- MDXG 6.85
- 52 Week Low
- HLX $5.52
- MDXG $5.47
- 52 Week High
- HLX $12.33
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- HLX 52.72
- MDXG 53.02
- Support Level
- HLX $6.26
- MDXG $6.98
- Resistance Level
- HLX $6.42
- MDXG $7.23
- Average True Range (ATR)
- HLX 0.21
- MDXG 0.18
- MACD
- HLX 0.06
- MDXG -0.03
- Stochastic Oscillator
- HLX 70.00
- MDXG 39.02
About HLX Helix Energy Solutions Group Inc.
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.